Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

IMUC EOM Pharmaceutical Holdings

Watchlist
0.610
-0.010-1.61%
Close  02/02 16:00 ET
High
0.610
Open
0.610
Turnover
109.19
Low
0.610
Pre Close
0.620
Volume
179.00
Market Cap
2.56M
P/E(TTM)
0.04
52wk High
0.940
Shares
4.19M
P/E(Static)
Loss
52wk Low
0.150
Float Cap
2.55M
Bid/Ask %
0.00%
Historical High
1600.000
Shs Float
4.18M
Volume Ratio
0.16
Historical Low
0.059
Dividend TTM
--
Div Yield TTM
--
P/B
0.74
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
0.610
Lot Size
1
Float Cap
2.55M
Bid/Ask %
0.00%
Historical High
1600.000
Shs Float
4.18M
Volume Ratio
0.16
Historical Low
0.059
Dividend TTM
--
P/B
0.74
Dividend LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
0.610
Lot Size
1
Price Forecast

News

Comment

Company Overview More
ImmunoCellular Therapeutics, Ltd. is a clinical-stage pharmaceutical company, focused on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. The company was founded on March 20, 1987 and is headquartered in Montvale, NJ.
CEO: --
Market: Pink Market
Listing Date: 08/11/2016
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist